by Stacey Johnson | Dec 2, 2022
The other day someone asked me if I was all ready for Christmas. It wasn’t even December yet! Bah humbug. I don’t have a tree yet, nor am I ready to deal with decorating my house. The only thing I start doing before December is shopping. Not that I’m finished, but I’m...
by Stacey Johnson | Nov 25, 2022
If manufacturing is the gatekeeper to success in the cell and gene therapy space, it’s not surprising that the topic regularly comes up when industry leaders come together to discuss the future or to tackle the challenges we face in commercializing cell and gene...
by Stacey Johnson | Nov 4, 2022
Despite valiant efforts by countless people and organizations, misinformation and a lack of public trust in science continue to be prevalent themes in 2022. Day two of the Till & McCulloch Meetings in Vancouver kicked off with an informative plenary exploring...
by Kevin Robb | Oct 27, 2022
One of the things that sets the Till & McCulloch Meetings (TMM) apart from other conferences, in my opinion, is the priority placed on trainee development. In part, the Stem Cell Network (SCN) achieves this through their support of the Trainee Communications...
by Kevin Robb | Oct 14, 2022
My heart is pounding, and my islets are secreting. Maybe it’s my fifth cup of sugary coffee kicking in, or maybe they’ve been inspired by the plenary session I’m recalling. While the former is more likely, I toy with the idea of the latter. In the “Clinical...
by Josh Dierolf | Oct 4, 2022
The COVID-19 pandemic has been a transformative period for many. Our values and perspectives have been put to the test as schools, workplaces, and day-to-day operations adjusted to the new ways of living. One aspect of the last few years has been coined “The Great...
by Stacey Johnson | Sep 30, 2022
After returning from CellCAN’s 2022 Strategic Forum in Ottawa, Ontario, where Canada’s cell and gene therapy biomanufacturing community came together to share information and network, it is clear that the country’s biomanufacturing landscape is improving. As I and...
Comments